Detected ·
AMR Bio
——
AMR Bio, a biotech company tackling antimicrobial resistance, raised £1.3M led by EMV Capital to advance XF-73, a Phase 3-ready antimicrobial for pre-surgical decolonisation.
- Website
- amr-bio.com
- linkedin.com/company/amr-bio
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-05-22 15:43:19 UTC
- Signal ID
- 350384e2-1782-4cf5-b81c-65f1465827cb
As the API returns it
{
"id": "350384e2-1782-4cf5-b81c-65f1465827cb",
"created_at": "2026-05-22T15:43:19.255111Z",
"company_name": "AMR Bio",
"company_website_url": "amr-bio.com",
"company_linkedin_url": "https://www.linkedin.com/company/amr-bio",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*AMR Bio, a biotech company tackling antimicrobial resistance, raised £1.3M led by EMV Capital to advance XF-73, a Phase 3-ready antimicrobial for pre-surgical decolonisation.*"
}